Intriguingly, however, semaglutide treatment did not directly improve retinal ganglion cell survival in this context
In the same study, they found that: 99.5 percent of GI events werent serious 98 percent of GI issues were mild or moderate Only 4.3 percent of participants stopped taking semaglutide due to GI side effects But, its important to remember that medication affects everyone differently
Methods: Disproportionality analysis was used to evaluate the association between GLP-1 RAs and gastrointestinal adverse events
The pain report provides valuable insights for individuals with a history of physical trauma, as well as those experiencing musculoskeletal, neuropathic pain, fibromyalgia, and arthritis, including osteoarthritis and rheumatoid arthritis
If your clinic is currently offering or advertising compounded GLP-1s in Connecticut, now is the time to reassess
This doesn't mean you need to adopt an extreme diet or workout routine